Lipella Pharmaceuticals Inc. Profile Avatar - Palmy Investing

Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formula…

Biotechnology
US, Pittsburgh [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of LIPO's Analysis
CIK: 1347242 CUSIP: 53630L100 ISIN: US53630L1008 LEI: - UEI: -
Secondary Listings
LIPO has no secondary listings inside our databases.